Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
1. 2. 3. 4. 5.
Vector- Anopheles
Antimalricos I
Frmacos
Estrutura qumica
Mecanismo de aco
4-aminoquinolenas
8-aminoquinolenas
desconhecido
Antimalricos II
Mecanismo de aco desconhecido Inib. reduct. ac. dihidroflico Inib. reduct. ac. dihidroflico Ant. PABA Inib. sntese proteica (30s) Inib. Transporte de electres na mitocndria
Fansidar+
Malarone
Antimalricos III
Frmacos Artemisinina (qinghausu) Artemether Artesunato Estrutura qumica Endoperxido (lactona sesquiterpnica) Mecanismo de aco Formao de radicais livres aps a clivagem do endoperoxido
Cloroquina
Farmacocintica Boa absoro oral (sal fosfato) Tambm i.m. Met. heptica Vol. Dist. 100-1000 L/kg T1/2 1-2 meses Excreo renal Efeitos laterais (normalmente bem tolerada) G.I. (nusea, dor abdominal, anorexia Urticria (raa negra) Dermatite alopecia Alt. Viso Hipotenso (grave qd. parentrica) Alt. ECG Hemlise grave (G6PD) Reaces neuropsiquitricas Miopatia Retinopatia agranolocitose
Cloroquina
Amodiaquina
Primaquina
Farmacocintica Boa absoro oral T1/2 -3-8 h Metab. Heptica (met. activos) Excreo renal
Quinina
Farmacocintica Boa absoro oral e i.m. i.V (quinina HCL e gluconato) Met. Heptica T1/2 11 h (> malaria) Excreo renal (ajuste nos doentes com I.R.) (aumenta os niveis de varfarina e digoxina) Efeitos laterais (toxicidade elevada) Cinchonismo: zumbidos, cefaleias, nuseas, vmitos, alt. Viso G.I. Reaces de hipersensibilidade Hemlise grave (G6PD), hemoglubinria Leucopenia Agranulocitose Trombocitopenia Hipoglicemiatromboflebite Contraes uterinas (3 trimestre) Hipotenso (grave qd. Parentrica) Alt. ECG
Quinina
Esquizonticida/gametocida- formas eritrocitrias (trofozoitos, gametcitos)
Mefloquina
Farmacocintica Boa absoro oral (no h parentrica, iiritao local) Ligao s PP elevada Extensa distribuio Eliminao biliar T1/2 20 dias (da uma dose nica por semana) Efeitos adversos G.I. Tonturas Alteraes do sono Alteraes do comportamento Reaces neuropsiquitricas (depresso, confuso, psicose, convulses) Leucocitose Trombocitopenia Arritmias
Mefloquina
Esquizonticida/gametocida- formas eritrocitrias (trofozoitos, gametcitos)
Tratamento e profilaxia da Malaria P. falciparum ou outras espcies desde que resistentes cloroquina) No til em situaes graves
- Aumento de resistncias dos plasmdios quimioterapia - Aumento de resistncias do Mosquito Anopheles /vector) aos insecticidas - Alteraes ecolgicas e Climatricas - Aumento de viagens internacionais para locais com Malaria endmica
http://www.who.int/ith/countrylist BRAZIL Capital: Brasilia Altitude: 1000 m Malaria: Malaria riskP. vivax (77%), P. falciparum (23%)is present in most forested areas below 900 m within the nine states of the Legal Amazonia region (Acre, Amap, Amazonas, Maranho (western part), Mato Grosso (northern part), Par (except Belm City), Rondnia, Roraima and Tocantins. Transmission intensity varies from municipality to municipality, but is higher in jungle areas of mining, lumbering and agricultural settlements less than 5 years old, than in the urban areas, including in large cities such as Prto Velho, Boa Vista, Macap, Manaus, Santarm and Maraba, where the transmission occurs on the periphery of these cities. In the states outside Legal Amazonia, malaria transmission risk is negligible or non-existent. Multidrug-resistant P. falciparum reported. Recommended prophylaxis in risk areas: mefloquine.
http://www.who.int/ith/countrylist
DOMINICAN REPUBLIC Capital: Santo Domingo Altitude: 380 m No vaccination requirements for any international traveller. Malaria: Low malaria riskexclusively due to P. falciparumexists throughout the year, especially in rural areas of the western provinces such as Castauelas, Hondo Valle and Pepillo Salcedo. There is no evidence of P. falciparum resistance to any antimalarial drug. Recommended prophylaxis in risk areas: chloroquine.
http://www.who.int/ith/countrylist
GUINEA-BISSAU Capital: Bissau Altitude: 0 m Malaria: Malaria riskpredominantly due to P. falciparumexists throughout the year in the whole country. Resistance to chloroquine reported. Recommended prophylaxis: mefloquine
http://www.who.int/ith/countrylist
MOZAMBIQUE Capital: Maputo Altitude: 50 m Malaria: Malaria riskpredominantly due to P. falciparumexists throughout the year in the whole country. P. falciparum resistant to chloroquine and sulfadoxine pyrimethamine reported. Recommended prophylaxis: mefloquine.
http://www.who.int/ith/countrylist
INDIA Capital: New Delhi Altitude: 210 m Malaria: Malaria risk exists throughout the year in the whole country below 2000 m, with 40% to 50% of cases due to P. falciparum. There is no transmission in parts of the states of Himachal Pradesh, Jammu and Kashmir, and Sikkim. P. falciparum resistance to chloroquine and sulfadoxinepyrimethamine reported. Recommended prophylaxis in risk areas: chloroquine plus proguanil. In Assam: mefloquine